Back
Artiva Biotherapeutics Stock Price Chart
Free Access to "King of the Quants" Stock Rating System
[Claim Your 3 Free Grades Now]
Sell
3
ARTV
Artiva Biotherapeutics
Last Price:
$6.53
Seasonality Move:
--
7 Day Trial
ALL ACCESS PASS
$
7
Access "King of the Quants" Stock Rating System FREE!
[Claim Your 3 Free Grades Now]-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ARTV is experiencing selling pressure, which indicates risk of future bearish movement.
Artiva Biotherapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.16 | Sell |
| 20-day SMA: | 9.54 | Sell |
| 50-day SMA: | 10.94 | Sell |
| 200-day SMA: | 0 | Buy |
| 8-day EMA: | 7.84 | Sell |
| 20-day EMA: | 9.16 | Sell |
| 50-day EMA: | 10.33 | Sell |
| 200-day EMA: | 8.04 | Sell |
Artiva Biotherapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.12 | Sell |
| Relative Strength Index (14 RSI): | 25.32 | Sell |
| Chaikin Money Flow: | -61479 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.34 - 11.28) | Sell |
| Bollinger Bands (100): | (9.71 - 13.49) | Sell |
Artiva Biotherapeutics Technical Analysis
| Jan 3 | Jan 6 | Jan 7 | Jan 8 | Jan 10 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 03 | 06 | 07 | 08 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Artiva Biotherapeutics Stock
Is Artiva Biotherapeutics Stock a Buy?
-
Artiva Biotherapeutics share price is 6.53 while ARTV 8-day simple moving average is 8.16, which is a Sell signal.
-
The stock price of ARTV is 6.53 while Artiva Biotherapeutics 20-day SMA is 9.54, which makes it a Sell.
-
Artiva Biotherapeutics 50-day simple moving average is 10.94 while ARTV share price is 6.53, making it a Sell technically.
-
ARTV stock price is 6.53 and Artiva Biotherapeutics 200-day simple moving average is 0.00, creating a Buy signal.
ARTV Technical Analysis vs Fundamental Analysis
Sell
3
Artiva Biotherapeutics (ARTV)
is a Sell
Is Artiva Biotherapeutics a Buy or a Sell?
-
Artiva Biotherapeutics stock is rated a SellThe current Artiva Biotherapeutics [ARTV] share price is $6.53. The Score for ARTV is 3, which is 94% below its historic median score of 50, and infers higher risk than normal.
Artiva Biotherapeutics Stock Info
Market Cap:
114.8M
Price in USD:
6.53
Share Volume:
68.1K
Artiva Biotherapeutics 52-Week Range
52-Week High:
17.31
52-Week Low:
6.50
Sell
3
Artiva Biotherapeutics (ARTV)
is a Sell
Artiva Biotherapeutics Share Price Forecast
-
What is the Artiva Biotherapeutics stock price today?The Artiva Biotherapeutics stock price is 6.53 USD today.
-
Will ARTV stock go up or go down?Artiva Biotherapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is Artiva Biotherapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Artiva Biotherapeutics is overvalued.
Is Artiva Biotherapeutics Stock a Buy?
-
Artiva Biotherapeutics share price is 6.53 while ARTV 8-day exponential moving average is 7.84, which is a Sell signal.
-
The stock price of ARTV is 6.53 while Artiva Biotherapeutics 20-day EMA is 9.16, which makes it a Sell.
-
Artiva Biotherapeutics 50-day exponential moving average is 10.33 while ARTV share price is 6.53, making it a Sell technically.
-
ARTV stock price is 6.53 and Artiva Biotherapeutics 200-day simple moving average is 8.04, creating a Sell signal.
Fundamental Analysis of Artiva Biotherapeutics
Is Artiva Biotherapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.47 per share, and a decrease next year of $0.15 per share.
Technical Analysis of Artiva Biotherapeutics
Should I short Artiva Biotherapeutics stock?
-
ARTV Moving Average Covergence Divergence (MACD) indicator is -1.12, suggesting Artiva Biotherapeutics is a Sell
-
Artiva Biotherapeutics Relative Strength Index (RSI) is 25.32, which suggest Artiva Biotherapeutics is oversold
-
The Bollinger Bands (25) for Artiva Biotherapeutics is (8.34 - 11.28), which suggest Artiva Biotherapeutics is a Sell
-
The Bollinger Bands (100) for Artiva Biotherapeutics is (9.71 - 13.49), which suggest Artiva Biotherapeutics is a Sell
* Artiva Biotherapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.